Willy Michel
Willy Michel is the founder of Ypsomed, a Swiss MedTech company known for its insulin delivery systems. He has played a pivotal role in the company's growth since its IPO in 2004 and continues to be influential in its strategic decisions, including the recent sale of its diabetes care segment to TecMed AG, a move that reflects his commitment to focusing on core business areas.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Willy Michel is the founder of Ypsomed and played a significant role in the company's history.
6